Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/47622
Title: | KEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER |
Authors: | CASTRO, Gilberto de; KUDABA, Iveta; WU, Yi-Long; LOPES, Gilberto; KOWALSKI, Dariusz M.; TURNA, Hande Z.; CAGLEVIC, Christian; ZHANG, Li; KARASZEWSKA, Boguslawa; LAKTIONOV, Konstantin K.; SRIMUNINNIMIT, Vichien; BONDARENKO, Igor; KUBOTA, Kaoru; MUKHERJEE, Rinee; LIN, Jianxin; SOUZA, Fabricio; MOK, Tony S. K.; CHO, Byoung Chul |
Citation: | JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, suppl.2, p.A390-A390, 2021 |
Appears in Collections: | Comunicações em Eventos - FM/MDR Comunicações em Eventos - HC/ICESP Comunicações em Eventos - LIM/24 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.